Evidence map›Paper›PMID 35699096›Full record

ArticleJournal of comparative effectiveness research2022

Impact of the COVID-19 pandemic on healthcare resource utilization across selected disease areas in the USA.

Kayla Engelbrecht, Srinjoy Roy, Gorana Capkun, Kristijan Kahler, Melvin Olson

Abstract read
In one paragraph

Article in Journal of comparative effectiveness research, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed.

  1. Intubated COVID-19 Patients More Likely to Develop Subglottic Stenosis.Laryngoscope investigative otolaryngology · 2026
    Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Kayla EngelbrechtRWE Specialist, Real World Evidence, CTS CONEXTS, Novartis Pharmaceuticals UK Ltd, London, W12 7FQ, UK.ORCID 0000-0003-3574-0829
Srinjoy RoyRWE Scientific Data Analyst, Real World Evidence, Novartis Healthcare Private Limited, Salarpuria-Sattva Knowledge City, Raidurg, Rangareddy District, Madhapur/Hyderabad, 500081, Telangana.ORCID 0000-0002-0206-5604
Gorana CapkunGlobal Head RWD Analytics & Evidence Enablement, Novartis Oncology, Basel, 4056, Switzerland.ORCID 0000-0001-9566-4456
Kristijan KahlerGlobal Head External Data Partnerships, Novartis Pharmaceuticals Corporation, East Hanover, NJ 07936, USA.ORCID 0000-0002-8227-8879
Melvin OlsonGlobal Head of Integrated Evidence Strategy & Innovation, Global Medical Affairs, Novartis Pharma AG, Basel, 4056, Switzerland.ORCID 0000-0002-2870-4443

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

COVID-19Delivery of Health CareHumansOutpatientsPandemicsPatient Acceptance of Health CareRetrospective StudiesUnited StatesCOVID-19HCRUhealthcare spendinghospital visitsOptum claimsoutpatient visitsreal-world datatelemedicine

Identifiers

PMID35699096
PMCPMC9251631

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.